Blue Marlin Therapeutics, Inc. — Form D

Blue Marlin Therapeutics, Inc. of CHARLOTTESVILLE, VA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-21. $100K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-10-21
• Form: D
• Accession: 0002092364-25-000001
• Industry: Biotechnology
• Exemptions: 06b
• Amount sold: $100K
• Minimum investment: $1
• Investors: 2
• Date of first sale: 2025-10-06
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-561543

Issuer

• Name: Blue Marlin Therapeutics, Inc.
• CIK: 0002092364
• Entity type: Limited Liability Company
• Jurisdiction: DELAWARE
• Incorporated: 2025
• Address: 200 GARRETT STREET, CHARLOTTESVILLE, VA, 22902
• Phone: 434-980-8104

Officers, directors & promoters (2)

More

• CIK 2092364 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search